ShcA Protects against Epithelial–Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation
暂无分享,去创建一个
R. Derynck | R. Akhurst | A. Mirza | Susan M. Smith | Y. Katsuno | Erine H. Budi | Baby-Periyanayaki Muthusamy | Matthew K Lee | Yoko Katsuno
[1] Shireen Khan,et al. Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms , 2015, mAbs.
[2] L. McCaffrey,et al. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling , 2015, Molecular biology of the cell.
[3] R. Derynck,et al. The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors , 2015, Science Signaling.
[4] R. Derynck,et al. Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. , 2014, Current opinion in cell biology.
[5] D. Medici,et al. Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.
[6] Morag Park,et al. p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition , 2014, Molecular and Cellular Biology.
[7] Y. Henis,et al. Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β , 2014, Molecular Biology of the Cell.
[8] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[9] Shuning He,et al. Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model , 2013, Breast Cancer Research.
[10] Ursula Pieper,et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. , 2013, Cell stem cell.
[11] T. Pawson,et al. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression. , 2013, Cancer research.
[12] Tony Pawson,et al. Temporal regulation of EGF signaling networks by the scaffold protein Shc1 , 2013, Nature.
[13] S. Arold,et al. Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli , 2013, Nature Structural &Molecular Biology.
[14] Robert G. Parton,et al. Caveolae as plasma membrane sensors, protectors and organizers , 2013, Nature Reviews Molecular Cell Biology.
[15] Samy Lamouille,et al. TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression , 2013, Current opinion in oncology.
[16] T. Pawson,et al. The ShcA SH2 domain engages a 14-3-3/PI3′K signaling complex and promotes breast cancer cell survival , 2012, Oncogene.
[17] Nina Jones,et al. Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. , 2012, The Biochemical journal.
[18] C. Heldin,et al. Induction of epithelial-mesenchymal transition by transforming growth factor β. , 2012, Seminars in cancer biology.
[19] R. Weinberg,et al. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.
[20] J. Massagué. TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.
[21] Andrea I. McClatchey,et al. Spatial regulation of receptor tyrosine kinases in development and cancer , 2012, Nature Reviews Cancer.
[22] James W. Smyth,et al. TGF-β-induced activation of mTOR complex 2 drives epithelial–mesenchymal transition and cell invasion , 2012, Journal of Cell Science.
[23] Luzhe Sun,et al. Mutant p53 Disrupts Role of ShcA Protein in Balancing Smad Protein-dependent and -independent Signaling Activity of Transforming Growth Factor-β (TGF-β)* , 2011, The Journal of Biological Chemistry.
[24] C. Meyer,et al. Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes. , 2011, Journal of hepatology.
[25] Harvey T. McMahon,et al. Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.
[26] H. Chapman,et al. Epithelial-mesenchymal interactions in pulmonary fibrosis. , 2011, Annual review of physiology.
[27] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[28] K. Burg,et al. Matrix compositions and the development of breast acini and ducts in 3D cultures , 2010, In Vitro Cellular & Developmental Biology - Animal.
[29] Kohei Miyazono,et al. TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.
[30] Marilyn Goudreault,et al. The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1 , 2010, The EMBO journal.
[31] M. Rajendran,et al. p66Shc—a longevity redox protein in human prostate cancer progression and metastasis , 2010, Cancer and Metastasis Reviews.
[32] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[33] R. Derynck,et al. Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. , 2009, Developmental cell.
[34] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[35] Ye Guang Chen,et al. Specific Activation of Mitogen-activated Protein Kinase by Transforming Growth Factor- Receptors in Lipid Rafts Is Required for Epithelial Cell Plasticity Transforming Growth Factor (tgf)- Regulates a Spectrum of Cellular Events, including Cell Proliferation, Differentiation, and Migration. in Add , 2008 .
[36] Y. Radhakrishnan,et al. Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells* , 2008, Journal of Biological Chemistry.
[37] R. Derynck,et al. The type I TGF-β receptor is covalently modified and regulated by sumoylation , 2008, Nature Cell Biology.
[38] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[39] T. Pawson,et al. ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.
[40] W. Muller,et al. Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion , 2008, Molecular and Cellular Biology.
[41] Jing Qing,et al. TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .
[42] Samy Lamouille,et al. Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway , 2007, The Journal of cell biology.
[43] C. Waterman-Storer,et al. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases , 2007, The Journal of cell biology.
[44] R. Philp,et al. PKC δ phosphorylates p52ShcA at Ser29 to regulate ERK activation in response to H2O2 , 2007 .
[45] Haiyan I. Li,et al. Purification and unique properties of mammary epithelial stem cells , 2006, Nature.
[46] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[47] C. Heldin,et al. Non-Smad TGF-β signals , 2005, Journal of Cell Science.
[48] S. Goff,et al. ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. , 2005, Molecular biology of the cell.
[49] C. Heldin,et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.
[50] H. Moses,et al. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.
[51] P. Pelicci,et al. p66SHC Promotes Apoptosis and Antagonizes Mitogenic Signaling in T Cells , 2004, Molecular and Cellular Biology.
[52] R. Cordera,et al. Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae. , 2003, Endocrinology.
[53] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[54] M. Vieth,et al. Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. , 2003, Journal of medicinal chemistry.
[55] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[56] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[57] Jeffrey L. Wrana,et al. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.
[58] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[59] Yoav I. Henis,et al. Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. , 2002, Molecular biology of the cell.
[60] P. Pelicci,et al. The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway , 2002, Molecular and Cellular Biology.
[61] A. Faisal,et al. Serine/Threonine Phosphorylation of ShcA , 2002, The Journal of Biological Chemistry.
[62] J. Doré,et al. Internalization-Dependent and -Independent Requirements for Transforming Growth Factor β Receptor Signaling via the Smad Pathway , 2002, Molecular and Cellular Biology.
[63] A. Reith,et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.
[64] Malgorzata Kisielow,et al. Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. , 2002, The Biochemical journal.
[65] Kodi S Ravichandran,et al. Signaling via Shc family adapter proteins , 2001, Oncogene.
[66] M. Bitzer,et al. Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.
[67] P. Pelicci,et al. Evolution of Shc functions from nematode to human. , 2000, Current opinion in genetics & development.
[68] H. Moses,et al. Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.
[69] T Pawson,et al. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. , 2000, Genes & development.
[70] Pier Paolo Pandolfi,et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.
[71] E. Reddy,et al. Signaling by dual specificity kinases , 1998, Oncogene.
[72] J. Smith,et al. Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. , 1998, Cellular signalling.
[73] K. Kinzler,et al. Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.
[74] Kenneth M. Yamada,et al. The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition , 1997, The Journal of cell biology.
[75] R. Derynck,et al. The Type II Transforming Growth Factor-β Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues* , 1997, The Journal of Biological Chemistry.
[76] G. Superti-Furga,et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor–MAP kinase–fos signalling pathway , 1997, The EMBO journal.
[77] R. Derynck,et al. Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.
[78] R. Derynck,et al. Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex , 1995, The Journal of Biological Chemistry.
[79] T. Pawson,et al. A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase , 1995, Molecular and cellular biology.
[80] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] R. Derynck,et al. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.
[82] S. Inui,et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct , 1994 .
[83] M. Lazzara,et al. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. , 2014, Cancer research.
[84] Cécile Boscher,et al. Caveolin-1: role in cell signaling. , 2012, Advances in experimental medicine and biology.
[85] Samy Lamouille,et al. TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling , 2009 .
[86] Ying E Zhang,et al. Non-Smad pathways in TGF-β signaling , 2009, Cell Research.
[87] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.